Table 1.
Aneurysm group (n=63) | Controls (n=19) | |
Demographics | ||
Male/female | 56/7 | 17/2 |
Age, years | 76.1±6.8 | 69.4±5.8 |
Aneurysm diameter, cm | 4.33±0.73 | – |
Risk factors | ||
Current or ex-smoker | 47 (75%) | 14 (74%) |
Hypertension | 26 (42%) | 7 (37%) |
Type two diabetes mellitus | 5 (8%) | 1 (5%) |
Prior MI | 14 (22%) | 11 (58%) |
Prior stroke | 8 (13%) | 4 (21%) |
Prior PVD | 9 (14%) | 4 (21%) |
Medications | ||
Aspirin | 48 (76%) | 16 (84%) |
Statin | 53 (84%) | 19 (100%) |
Beta-blocker | 21 (33%) | 10 (53%) |
ACEI or ARB | 30 (48%) | 13 (68%) |
ACEI, ACE inhibitor; ARB, angiotensin-receptor blocker; MI, myocardial infarction; PVD, peripheral vascular disease.